Genetic selection for high acute inflammatory response confers resistance to lung carcinogenesis in the mouse

Experimental Lung Research

Volumn 31, Issue 1, 2005, Pages 105-116

  Ribeiro, Orlando Garcia ^a   Cabrera, Wafa Hanna ^a   Maria, Durvanei Augusto ^a   De Franco, Marcelo ^a   Massa, Solange ^a   Di Pace, Roberte Francisco ^a   De Souza, Vinicius Ricardo Cuña ^a   Starobinas, Nancy ^a   Semen, Michel ^a   Ibañez, Olga Martinez ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Acute inflammation; Genetic selection; Lung chemical carcinogenesis; Mouse

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; NIMESULIDE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER INCIDENCE; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; FEMALE; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC SELECTION; INFLAMMATION; INHERITANCE; LUNG CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS;

ACUTE DISEASE; ADENOCARCINOMA; ANIMALS; CARCINOGENS; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION; LEUKOCYTE COUNT; LUNG NEOPLASMS; MICE; MICE, INBRED STRAINS; QUANTITATIVE TRAIT, HERITABLE; SELECTION (GENETICS); URETHANE;

EID: 19944428715     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490495237     Document Type: Conference Paper

References (39)

1. Manenti G, Nomoto T, De Gregorio L, Gariboldi M, Stefania F, Nagao M, Dragani TA: Predisposition to lung tumorigenesis. Toxicol Lett. 2000;113:257-263.
2. Budillon A: Molecular genetics of cancer: oncogenes and tumor suppressor genes Cancer. 1995;76:1869-1873.
3. Perera FP: Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst. 1996;88:496-509.
4. Lozupone F, Luciani F, Venditti M, Rivioltini L, Pupa S, Parmiani G, Belardelli F, Fais S: Murine granulocytes control human tumor growth in SCID mice. Int J Cancer. 2000;87:569-573.
5. Fioretti F, Fradelizi D, Stoppacciaro A, Ramponi S, Minty A, Sozzani S, Garlanda C, Vecchi A, Mantovani A: Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotatic protein-3 (MPC-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J Immunol. 1998;161:342-346.
6. Hevin MB, Friguet B, Fauve RM: Inflammation and anti-tumor resistance. V. Production of a cytostatic factor following cooperation of elicited polymorphonuclear leukocytes and macrophages. Int J Cancer. 1990;46:533-538.
7. Soiffer R, Lynch T, Mihm M, Jung K, Rhuda C, Schmollinger JC, Hodi FS, Liebster L, Lam P, et al: Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent anti-tumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci USA. 1998;22:13141-13146.
8. O'Byrne KJ, Dalgleish AG: Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer. 2001;85:473-483.
9. Albina JE, Reichner JS: Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasic Rev. 1998;17:39-53.
10. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Paspaeakis M, Kollias G, Balkwill F: Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med. 1999;5:828-831.
11. Shacter E, Weitzman SA: Chronic inflammation and cancer. Oncology. 2002;16:217-226.
12. Ibanez OM, Stiffel C, Ribeiro OG, Cabrera WK, Massa S, De Franco M, Sant'Anna OA, Decreusefond C, Mouton D, Siqueira M, Biozzi G: Genetics of nonspecific immunity: I. Bidirectional selective breeding of lines of mice endowed with maximal or minimal inflammatory responsiveness. Eur J Immunol. 1992;22:2555-2563.
13. Ribeiro OG, Maria DA, Adriouch S, Pechberty S, Ibañez OM, Seman M: Convergent alteration of granulopoiesis, chemotatic activity and neutrophil apoptosis in mice genetically selected for high acute inflammatory response. J Leuk Biol. 2003;74:497-506.
14. Araujo LMM, Ribeiro OG, Siqueira M, De Franco M, Massa S, Cabrera WHK, Mouton D, Seman M, Ibañez O M: Innate resistance to infections by intracellular bacteria differs in mice selected for maximal or minimal acute inflammatory reactivity. Eur J Immunol. 1998;28:2913-2920.
15. Vigar ND, Cabrera WK, Araujo LM, Ribeiro OG, Ogata TP, Siqueira M, Ibañez OM, De Franco M: Pristane-induced arthritis in mice selected for maximal or minimal acute inflammatory reaction. Eur J Immunol. 2000;30:431-437.
16. Biozzi G, Ribeiro OG, Saran A, Araujo LMM, Maria DA, De Franco M, Cabrera WHK, Sant'Anna OA, Massa S, Pioli C, Doria G, Decreusefond C, Mouton D, Siqueira M, Ibañez OM: Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse. Carcinogenesis. 1998;19:337-346.
17. Maria DA, Ribeiro OG, Pizzocaro K, De Franco M, Cabrera WK, Starobinas N, Gallois V, Siqueira M, Seman M, Ibañez OM: Resistance to melanoma metastases in mice selected for high acute inflammatory response. Carcinogenesis. 2001;22:337-342.
18. Maria DA, Manenti G, Galbiati F, Ribeiro OG, Cabrera WK, Barrera RG, Pettinicchio A, De Franco M, Starobinas N, Siqueira M, Dragani TA, Ibañez OM: Pulmonary adenoma susceptibility (Pas 1) locus affects inflammatory response. Oncogene. 2003;22:426-432.
19. Dragani TA, Manenti G, Pierotti MA: Genetics of murine lung tumors. Adv Cancer Res. 1995;67:83-112.
20. Manenti G, Stafford A, De Gregorio L, Gariboldi M, Falvella FS, Avner P, Dragani TA: Linkage disequilibrium and physical mapping of Pas1 in mice. Genome Res. 1999;9:639-646.
21. Giardiello FM, Offerhans GJ, Dubois RN: The role of nonsteroidal anti-inflammatory drugs in colorectal cancer. Eur J Cancer. 1995;31:1071-1076.
22. Castonguay A, Duperron C: Chemo-preventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis. 1997;18:1001-1006.
23. Rosenberg DW, Liu Y: Induction of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesis. Cancer Lett. 1995;92:209-214.
24. Malkinson AM, Radcliffe RA, Bauer AK: Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice. Carcinogenesis. 2002;23:411-417.
25. Qin Z, Kim HJ, Hemme J, Blankenstein T: Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction. J Exp Med. 2002;195:1479-1490.
26. Clish CB, Gronert K, Serhan CN: Local and systemic delivery of an aspirin-triggered lipoxin stable analog inhibits neutrophil trafficking. Ann N Y Acad. 2000;905:274-278.
27. Stanford SJ, Pepper JR: Release of GM-CSF and G-CSF by human arterial and venous smooth muscle cells: differential regulation by COX-2. Br J Pharmacol. 2000;129:835-838.
28. Bol DK, Rowley B, Ho C, Pilz B, Dell D, Swerdel M, Kiguchi K, Muga S, Klein R, Fischer SM: Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. Cancer Res. 2002;62:2516-2521.
29. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA: Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999;6:621-622.
30. Yao R, Rioux N, Castonguay A, You M: Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal ant-inflammatory drugs chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res. 2000;26:731-742.
31. Berman KS, Verma UN, Marburg G, Minna JD, Cobb MH, Gaynor RB: Sulindac enhances tumor necrosis factor-α-mediated apoptosis of lung cancer cells lines by inhibition of nuclear factor-κB. Clin Cancer Res. 2002;8:354-360.
32. Bauer AK, Dwyer-Nield LD, Malkinson AM: High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis. 2000;21:543-550.
33. Leung KH, Ip MM, Koren HS: Regulation of human natural killing. IV. Role of lipoxygenase in regulation of natural killing activity. Scand J Immunol. 1986;24:371-380.
34. Voth R, Chmielarczyk W, Storch E, Kirchner H: Induction of natural killer cell activity in mice by injection of indomethacin. Nat Immuno Cell Growth Regul. 1986;5:317-324.
35. Gorelik E, Herberman RB: Susceptibility of various strains of mice to urethane-induced lung tumors and depressed natural killer cell activity. J Natl Cancer Inst. 1981;67:1317-1322.
36. Allen JW, Stoner GD, Pereira MA, Backer LC, Sharief Y, Hatch GG, Campbell JA, Stead AG, Nesnow S: Tumorigenesis and genotoxicity of ethyl carbamate and vinyl carbamate in rodent cells. Cancer Res. 1986;46:4911-4915.
37. Castonguay A, Rioux N, Duperron C, Jalbert G: Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis. Exp Lung Res. 1998;24:605-615.
38. Dragani T: 10 years of mouse cancer modifier loci: human relevance. Cancer Res. 2003;63:3011-3018.
39. Demant P: Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat Rev/Genet. 2003;4:721-735.